These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 22316494
1. Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics. Xiong Q, Zhong Q, Zhang J, Yang M, Li C, Zheng P, Bi LJ, Ge F. J Proteome Res; 2012 Apr 06; 11(4):2078-90. PubMed ID: 22316494 [Abstract] [Full Text] [Related]
2. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death. Borghouts C, Tittmann H, Delis N, Kirchenbauer M, Brill B, Groner B. Mol Cancer Res; 2010 Apr 06; 8(4):539-53. PubMed ID: 20371673 [Abstract] [Full Text] [Related]
3. Identification of direct targets for the miR-17-92 cluster by proteomic analysis. Kanzaki H, Ito S, Hanafusa H, Jitsumori Y, Tamaru S, Shimizu K, Ouchida M. Proteomics; 2011 Sep 06; 11(17):3531-9. PubMed ID: 21751348 [Abstract] [Full Text] [Related]
4. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer. Lin X, Lin BW, Chen XL, Zhang BL, Xiao XJ, Shi JS, Lin JD, Chen X. Biochem Biophys Res Commun; 2017 Dec 02; 493(4):1464-1470. PubMed ID: 28988111 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas. Yoon CJ, Chang MS, Kim DH, Kim W, Koo BK, Yun SC, Kim SH, Kim YS, Woo JH. Gastric Cancer; 2020 Sep 02; 23(5):780-795. PubMed ID: 32206940 [Abstract] [Full Text] [Related]
6. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung JH, Yun SM, Han I, Lee SG, Kim DK, Kang M, Chen CY, Lee JW, Kim SH. Eur J Pharmacol; 2011 Mar 01; 654(1):10-6. PubMed ID: 21172343 [Abstract] [Full Text] [Related]
7. TRIM8 modulates STAT3 activity through negative regulation of PIAS3. Okumura F, Matsunaga Y, Katayama Y, Nakayama KI, Hatakeyama S. J Cell Sci; 2010 Jul 01; 123(Pt 13):2238-45. PubMed ID: 20516148 [Abstract] [Full Text] [Related]
8. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells. Yagil Z, Kay G, Nechushtan H, Razin E. J Immunol; 2009 Feb 15; 182(4):2168-75. PubMed ID: 19201870 [Abstract] [Full Text] [Related]
9. Quantitative proteomic analysis of tumor reversion in multiple myeloma cells. Ge F, Zhang L, Tao SC, Kitazato K, Zhang ZP, Zhang XE, Bi LJ. J Proteome Res; 2011 Feb 04; 10(2):845-55. PubMed ID: 21080727 [Abstract] [Full Text] [Related]
10. A positive feedback loop between miR-181b and STAT3 that affects Warburg effect in colon cancer via regulating PIAS3 expression. Pan X, Feng J, Zhu Z, Yao L, Ma S, Hao B, Zhang G. J Cell Mol Med; 2018 Oct 04; 22(10):5040-5049. PubMed ID: 30054984 [Abstract] [Full Text] [Related]
11. MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma. Wang C, Ba X, Guo Y, Sun D, Jiang H, Li W, Huang Z, Zhou G, Wu S, Zhang J, Chen J. Sci Rep; 2017 Jan 25; 7():41456. PubMed ID: 28120918 [Abstract] [Full Text] [Related]
12. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J. Cancer Lett; 2011 Oct 01; 309(1):62-70. PubMed ID: 21664042 [Abstract] [Full Text] [Related]
13. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation. Ma J, Yang Y, Fu Y, Guo F, Zhang X, Xiao S, Zhu W, Huang Z, Zhang J, Chen J. Theranostics; 2018 Oct 01; 8(11):3022-3037. PubMed ID: 29896300 [Abstract] [Full Text] [Related]
14. miRNA-21 inhibition enhances RANTES and IP-10 release in MCF-7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration. Wang Z, Han J, Cui Y, Zhou X, Fan K. Biochem Biophys Res Commun; 2013 Sep 27; 439(3):384-9. PubMed ID: 23998932 [Abstract] [Full Text] [Related]
15. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer]. Gan L, Yin ZF, Li M. Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):419-21. PubMed ID: 18581899 [Abstract] [Full Text] [Related]
16. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. Pitari MR, Rossi M, Amodio N, Botta C, Morelli E, Federico C, Gullà A, Caracciolo D, Di Martino MT, Arbitrio M, Giordano A, Tagliaferri P, Tassone P. Oncotarget; 2015 Sep 29; 6(29):27343-58. PubMed ID: 26160841 [Abstract] [Full Text] [Related]
17. Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21. Ray S, Coulter DW, Gray SD, Sughroue JA, Roychoudhury S, McIntyre EM, Chaturvedi NK, Bhakat KK, Joshi SS, McGuire TR, Sharp JG. Mol Carcinog; 2018 Apr 29; 57(4):536-548. PubMed ID: 29280516 [Abstract] [Full Text] [Related]
18. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC. Circ Res; 2009 May 22; 104(10):1184-91. PubMed ID: 19390056 [Abstract] [Full Text] [Related]
19. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Kim WK, Park M, Kim YK, Tae YK, Yang HK, Lee JM, Kim H. Clin Cancer Res; 2011 Dec 15; 17(24):7584-94. PubMed ID: 22042971 [Abstract] [Full Text] [Related]
20. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, Hoshino S, Osaka Y, Tsuchida A, Kuroda M. Br J Cancer; 2013 Feb 19; 108(3):653-61. PubMed ID: 23322197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]